Monte Rosa Therapeutics (GLUE) shares soared 44.1% in the last trading session to close at $6.93. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 5% gain over the past four weeks. This surge in stock price came after the company announced that it entered into a multi-billion-dollar collaboration deal with pharma giant Novartis to develop novel therapies for immune-mediated diseases. Per the deal terms, Novartis will receive an ex ...